Myovant Sciences

About:

Myovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men.

Twitter/X: myovant

Top Investors: Hercules Capital, Novaquest Capital Management, Dainippon Sumitomo Pharma

Description:

Myovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men. The company's product capabilities and help continue to deliver innovative therapies addressing unmet patient needs in prostate cancer and women’s health. Myovant Sciences was established in 2016 and is based in Brisbane, California.

Total Funding Amount:

$540M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Brisbane, California, United States

Founded Date:

2016-01-01

Contact Email:

contact(AT)myovant.com

Founders:

Number of Employees: